GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Price-to-Operating-Cash-Flow

Duopharma Biotech Bhd (XKLS:7148) Price-to-Operating-Cash-Flow : 11.51 (As of Jul. 06, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Price-to-Operating-Cash-Flow?

As of today (2025-07-06), Duopharma Biotech Bhd's share price is RM1.37. Duopharma Biotech Bhd's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was RM0.12. Hence, Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow Ratio for today is 11.51.

The historical rank and industry rank for Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow or its related term are showing as below:

XKLS:7148' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.64   Med: 18.05   Max: 223.75
Current: 11.51

During the past 13 years, Duopharma Biotech Bhd's highest Price-to-Operating-Cash-Flow Ratio was 223.75. The lowest was 8.64. And the median was 18.05.

XKLS:7148's Price-to-Operating-Cash-Flow is ranked better than
68.27% of 684 companies
in the Drug Manufacturers industry
Industry Median: 18.235 vs XKLS:7148: 11.51

Duopharma Biotech Bhd's Cash Flow from Operations per share for the three months ended in Mar. 2025 was RM0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was RM0.12.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Duopharma Biotech Bhd was 65.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 22.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -0.10% per year.

During the past 13 years, Duopharma Biotech Bhd's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.40% per year. The lowest was -17.60% per year. And the median was 1.15% per year.


Duopharma Biotech Bhd Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Price-to-Operating-Cash-Flow Chart

Duopharma Biotech Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.92 35.74 21.76 24.71 14.37

Duopharma Biotech Bhd Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.67 23.33 14.02 14.37 10.08

Competitive Comparison of Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow falls into.


;
;

Duopharma Biotech Bhd Price-to-Operating-Cash-Flow Calculation

Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.37/0.119
=11.51

Duopharma Biotech Bhd's Share Price of today is RM1.37.
Duopharma Biotech Bhd's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Duopharma Biotech Bhd Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.

Duopharma Biotech Bhd Headlines

No Headlines